Novartis Pharmaceuticals CORPORATION
UEI NG61ZA8TADW3 CAGE 04520 Active East Hanover, NJ
Other Than Small Business · Data through October 1, 2026
Obligations by fiscal year
| Fiscal year | Obligations |
|---|---|
| FY2027 (partial year) | $8.4M |
| FY2026 | $39.9M |
| FY2025 | $8.6M |
| FY2024 | $0 |
| FY2023 | -$18.8M |
| FY2022 | $7.4M |
| FY2021 | $1.4M |
Agencies, NAICS, and PSC codes
| Agency | Obligations | Share |
|---|---|---|
| Department of Veterans Affairs | $55.9M | 119.3% |
| Department of Defense | $4.9M | 10.4% |
| Department of Justice | $44K | 0.1% |
| Department of Health and Human Services | -$14.0M | -29.8% |
| NAICS code | Obligations | Share |
|---|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | $60.9M | 129.8% |
| 541711 — Research and Development in Biotechnology | -$14.0M | -29.8% |
| PSC code | Obligations | Share |
|---|---|---|
| 6505 — Drugs and Biologicals | $59.8M | 127.6% |
| 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets | $981K | 2.1% |
| Q517 — Pharmacy Services | $46K | 0.1% |
| AN92 — R&D- Medical: Other (applied Research/exploratory Development) | -$14.0M | -29.8% |
Contract type and set-aside mix
| Contract pricing type | Obligations | Share |
|---|---|---|
| Firm Fixed Price | $46.9M | 99.9% |
| Fixed Price With Economic Price Adjustment | $23K | 0.1% |
| Set-aside type | Obligations | Share |
|---|---|---|
| Not Specified | $59.5M | 126.9% |
| No Set Aside Used. | -$12.6M | -26.9% |
Place of performance by state
| State | Obligations | Share |
|---|---|---|
| NJ | $25.9M | 55.2% |
| CA | $5.9M | 12.7% |
| CT | $3.3M | 7.1% |
| TX | $3.3M | 6.9% |
| MO | $2.7M | 5.7% |
| PA | $2.0M | 4.2% |
| AZ | $1.6M | 3.5% |
| MD | $981K | 2.1% |
| IL | $663K | 1.4% |
| NC | $626K | 1.3% |
Largest contract actions on file
| Award | Agency | Period of performance | Obligation | Record |
|---|---|---|---|---|
| HHSO100201700026C · NAICS 541711 | Department of Health and Human Services | September 14, 2017 – June 30, 2024 | $7.4M | View on USAspending |
| 36C24826F0082 · NAICS 325412 | Department of Veterans Affairs | February 24, 2026 – August 31, 2026 | $4.7M | View on USAspending |
| 36C25726N0205 · NAICS 325412 | Department of Veterans Affairs | February 7, 2026 – February 6, 2027 | $4.2M | View on USAspending |
| 36C26127N0063 · NAICS 325412 | Department of Veterans Affairs | October 1, 2026 – September 30, 2027 | $4.1M | View on USAspending |
| 36C25725N0190 · NAICS 325412 | Department of Veterans Affairs | February 7, 2025 – February 6, 2026 | $4.1M | View on USAspending |
| 36C26126F0007 · NAICS 325412 | Department of Veterans Affairs | October 1, 2025 – September 30, 2026 | $4.0M | View on USAspending |
| 36C26226N0112 · NAICS 325412 | Department of Veterans Affairs | November 1, 2025 – October 31, 2026 | $3.9M | View on USAspending |
| W81K0025FA195 · NAICS 325412 | Department of Defense | October 1, 2025 – September 30, 2026 | $3.2M | View on USAspending |
| 36C24126F0136 · NAICS 325412 | Department of Veterans Affairs | September 30, 2026 – September 29, 2027 | $2.5M | View on USAspending |
| 36C25026N0310 · NAICS 325412 | Department of Veterans Affairs | February 1, 2026 – December 31, 2026 | $2.4M | View on USAspending |
Parent company
Novartis Sanierungsstiftung (UEI YE3YG1FDWMC5)
Other UEIs under this parent
- Advanced Accelerator Applications Usa INC — UEI JNM4NBNHFE66
Similar contractors
- Ase Direct, INC. — $43.9M, Brentwood, TN
- Pharmacy Buying Association, INC. — $41.3M, Kansas City, MO
- Sofie CO. — $54.0M, Dulles, VA
- Golden State Medical Supply, INC. — $56.5M, Camarillo, CA
- Rls (usa) INC. — $27.7M, Lake Mary, FL
- Sagent Pharmaceuticals, INC — $66.6M, Schaumburg, IL
- Petnet Solutions, INC. — $26.9M, Knoxville, TN
- Nationwide Pharmaceutical LLC — $26.9M, San Antonio, TX
What the numbers show
119% of this contractor's obligations on file ($55.9M of $46.9M) came from a single agency, Department of Veterans Affairs.
No transaction in this record used a small-business set-aside; all obligations were awarded with no set-aside or an unspecified type.
Obligations increased from $8.6M in FY2025 to $39.9M in FY2026, the last closed fiscal year.
Source: USAspending.gov, U.S. Department of the Treasury. Contract transactions FY2021–FY2027, downloaded 2026-10-21. Figures are net obligations and can include de-obligations. Department of Defense data is published with a 90-day delay. View this contractor's largest contract on USAspending.gov.
To request removal of this profile, use the contact form and select "Removal request." Requests are processed within 30 days.